Publication | Closed Access

Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation

Cell TherapyTransplantationHaploidentical TransplantationVirus ReactivationImmunologyStem Cell TransplantationGraft SurvivalCd34+ CellHivMedicineCell TransplantationGraft Rejection